Results 131 to 140 of about 874,197 (275)
The board of directors and international decision-making [PDF]
, 2013 This paper develops a view of how specific elements of the directors' human and social capital can enhance a company's international performance. We have taken the view that the board is an active participant in the firm’s management, and we have ...
Barroso Castro, Carmen +2 more
core
Effect of chemotherapy on passenger mutations in metastatic colorectal cancer
Molecular Oncology, EarlyView.Changes in passenger mutation load and predicted immunotherapy response after chemotherapy treatment. Tumor cells rich with passenger mutations have increased sensitivity to chemotherapy. Correlation of passenger mutations with neoantigen load suggests highly mutated clones promote a more effective response to immunotherapy, and therefore, first‐line ...
Marium T. Siddiqui +6 more
wiley +1 more source
The ARIN 2020 Virtual Annual Business Meeting: By The ARIN Board of Directors. [PDF]
J Radiol Nurs, 2020 Keough C.
europepmc +1 more source
Social Networks in The Boardroom [PDF]
This paper provides empirical evidence consistent with the facts that (1) social networks may strongly affect board composition and (2) social networks may be detrimental to corporate governance.
Kramarz, Francis, Thesmar, David
core
CGIAR Center Statements on Genetic Resources, Intellectual Property Rights, and Biotechnology [PDF]
, 1999 A collection of statements presenting the position of CGIAR centers on genetic resources, intellectual property rights, and biotechnology. Most of these were approved by the CGIAR at its Mid-Term meeting in May 1998, and an additional three at ...
CGIAR Center Directors Committee +1 more
core
Molecular Oncology, EarlyView.The noncoding region of the genome plays a key role in regulating gene expression, and mutations within these regions are capable of altering it. Researchers have identified multiple functional noncoding mutations associated with increased cancer risk in the genome of breast cancer patients.
Arnau Cuy Saqués +3 more
wiley +1 more source
Strength through diversity: how cancers thrive when clones cooperate
Molecular Oncology, EarlyView.Intratumor heterogeneity can offer direct benefits to the tumor through cooperation between different clones. In this review, Kuiken et al. discuss existing evidence for clonal cooperativity to identify overarching principles, and highlight how novel technological developments could address remaining open questions.
Marije C. Kuiken +3 more
wiley +1 more source
Board diversity and performance of microfinance institutions (MFIS): Evidence from an emerging economy [PDF]
, 2018 Microfinance Institutions (MFIs) are important service providers of finance for unbanked people and have experienced a high growth over the past decades.
Locke, Stuart, Thrikawala, Sujani
core
Molecular Oncology, EarlyView.Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice +16 more
wiley +1 more source
Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib
Molecular Oncology, EarlyView.WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute +17 more
wiley +1 more source